cbdMD Inc (YCBD)
0.90
0.00 (0.00%)
USD |
NYAM |
Apr 25, 16:00
0.85
-0.05
(-5.56%)
After-Hours: 20:00
cbdMD Cash from Financing (TTM): -0.1994M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.1994M |
September 30, 2023 | -1.323M |
June 30, 2023 | -1.661M |
March 31, 2023 | -4.134M |
December 31, 2022 | -4.146M |
September 30, 2022 | -4.035M |
June 30, 2022 | 10.76M |
March 31, 2022 | 11.19M |
December 31, 2021 | 11.53M |
September 30, 2021 | 28.23M |
June 30, 2021 | 14.36M |
March 31, 2021 | 16.29M |
December 31, 2020 | 33.65M |
Date | Value |
---|---|
September 30, 2020 | 22.37M |
June 30, 2020 | 22.35M |
March 31, 2020 | 32.83M |
December 31, 2019 | 16.14M |
September 30, 2019 | 17.92M |
June 30, 2019 | 17.63M |
March 31, 2019 | 5.792M |
December 31, 2018 | 5.777M |
September 30, 2018 | 10.26M |
June 30, 2018 | 11.23M |
March 31, 2018 | 11.41M |
December 31, 2017 | 11.42M |
September 30, 2017 | 2.388M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-4.146M
Minimum
Dec 2022
33.65M
Maximum
Dec 2020
12.62M
Average
14.36M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |